Publications

Efficacy, Safety, and Patient-Reported Outcomes Across Young to Older Age Groups of Patients with Hr+/Her2-Advanced Breast Cancer Treated with Ribociclib plus Endocrine Therapy in the Randomized Monaleesa-2,-3, And-7 Trials

AuthID
P-017-ZR9

Author(s)

Hart, LL

Im, SA

Tolaney, SM

Campone, M

Pluard, T

Sousa, B

Freyer, G

Decker, T

Kalinsky, K

Sopher, G

Gao, MLS

Hu, HL

Kuemmel, S

Document Type

Article

Year published

2025

Published

in EUROPEAN JOURNAL OF CANCER, ISSN: 0959-8049

Volume: 217

Indexing

Wos^®

Scopus^®

Pubmed^®

Google Scholar^®

Publication Identifiers

DOI: 10.1016/j.ejca.2025.115225

Pubmed: 39826197

Scopus: 2-s2.0-85215321846

Wos: WOS:001404294400001

Source Identifiers

ISSN: 0959-8049

Export Publication Metadata

Marked List

Add to Marked List

Citations

Oops! It looks like you don't have access to this content.

This section is restricted to uses with b-on access.

CORE Conference

No information about CORE Rank

During the preprocessing phase, only publications of type 'Proceedings Paper' or 'Proceedings' are automatically processed to identify their CORE Rank.

TIP: If your publication's CORE Rank is missing, you can contact with your institutional manager to have the correct ranking manually added to the record.

Journal Factors

Oops! It looks like you don't have access to this content.

This section is restricted to uses with b-on access.

Full Text

Full Text @ sfx.b-on.pt

Efficacy, Safety, and Patient-Reported Outcomes Across Young to Older Age Groups of Patients with Hr+/Her2-Advanced Breast Cancer Treated with Ribociclib plus Endocrine Therapy in the Randomized Monaleesa-2,-3, And-7 Trials

Useful Links

Get Help

Federated Authentication (Click on the image)

Efficacy, Safety, and Patient-Reported Outcomes Across Young to Older Age Groups of Patients with Hr+/Her2-Advanced Breast Cancer Treated with Ribociclib plus Endocrine Therapy in the Randomized Monaleesa-2,-3, And-7 Trials

Useful Links

Get Help